BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24438103)

  • 1. Reconstruction of an active SOCS3-based E3 ubiquitin ligase complex in vitro: identification of the active components and JAK2 and gp130 as substrates.
    Kershaw NJ; Laktyushin A; Nicola NA; Babon JJ
    Growth Factors; 2014 Feb; 32(1):1-10. PubMed ID: 24438103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biophysical studies on interactions and assembly of full-size E3 ubiquitin ligase: suppressor of cytokine signaling 2 (SOCS2)-elongin BC-cullin 5-ring box protein 2 (RBX2).
    Bulatov E; Martin EM; Chatterjee S; Knebel A; Shimamura S; Konijnenberg A; Johnson C; Zinn N; Grandi P; Sobott F; Ciulli A
    J Biol Chem; 2015 Feb; 290(7):4178-91. PubMed ID: 25505247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SOCS box domain of SOCS3: structure and interaction with the elonginBC-cullin5 ubiquitin ligase.
    Babon JJ; Sabo JK; Soetopo A; Yao S; Bailey MF; Zhang JG; Nicola NA; Norton RS
    J Mol Biol; 2008 Sep; 381(4):928-40. PubMed ID: 18590740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SOCS box encodes a hierarchy of affinities for Cullin5: implications for ubiquitin ligase formation and cytokine signalling suppression.
    Babon JJ; Sabo JK; Zhang JG; Nicola NA; Norton RS
    J Mol Biol; 2009 Mar; 387(1):162-74. PubMed ID: 19385048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro ubiquitination of cytokine signaling components.
    Babon JJ; Laktyushin A; Kershaw NJ
    Methods Mol Biol; 2013; 967():261-71. PubMed ID: 23296736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flavanoids induce expression of the suppressor of cytokine signalling 3 (SOCS3) gene and suppress IL-6-activated signal transducer and activator of transcription 3 (STAT3) activation in vascular endothelial cells.
    Wiejak J; Dunlop J; Mackay SP; Yarwood SJ
    Biochem J; 2013 Sep; 454(2):283-93. PubMed ID: 23782265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch-induced Asb2 expression promotes protein ubiquitination by forming non-canonical E3 ligase complexes.
    Nie L; Zhao Y; Wu W; Yang YZ; Wang HC; Sun XH
    Cell Res; 2011 May; 21(5):754-69. PubMed ID: 21119685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The E3 ubiquitin ligase HOIL-1 induces the polyubiquitination and degradation of SOCS6 associated proteins.
    Bayle J; Lopez S; Iwaï K; Dubreuil P; De Sepulveda P
    FEBS Lett; 2006 May; 580(11):2609-14. PubMed ID: 16643902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncostatin M receptor-mediated signal transduction is negatively regulated by SOCS3 through a receptor tyrosine-independent mechanism.
    Stross C; Radtke S; Clahsen T; Gerlach C; Volkmer-Engert R; Schaper F; Heinrich PC; Hermanns HM
    J Biol Chem; 2006 Mar; 281(13):8458-68. PubMed ID: 16459330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of SOCS and VHL Proteins in Neuronal Differentiation and Development.
    Kanno H; Matsumoto S; Yoshizumi T; Nakahara K; Kubo A; Murata H; Shuin T; U HS
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOCS3 binds specific receptor-JAK complexes to control cytokine signaling by direct kinase inhibition.
    Kershaw NJ; Murphy JM; Liau NP; Varghese LN; Laktyushin A; Whitlock EL; Lucet IS; Nicola NA; Babon JJ
    Nat Struct Mol Biol; 2013 Apr; 20(4):469-76. PubMed ID: 23454976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of IL-6 family cytokines by SOCS3.
    Babon JJ; Varghese LN; Nicola NA
    Semin Immunol; 2014 Feb; 26(1):13-9. PubMed ID: 24418198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimeric complexes among ankyrin-repeat and SOCS-box protein 9 (ASB9), ElonginBC, and Cullin 5: insights into the structure and assembly of ECS-type Cullin-RING E3 ubiquitin ligases.
    Thomas JC; Matak-Vinkovic D; Van Molle I; Ciulli A
    Biochemistry; 2013 Aug; 52(31):5236-46. PubMed ID: 23837592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130.
    Lehmann U; Schmitz J; Weissenbach M; Sobota RM; Hortner M; Friederichs K; Behrmann I; Tsiaris W; Sasaki A; Schneider-Mergener J; Yoshimura A; Neel BG; Heinrich PC; Schaper F
    J Biol Chem; 2003 Jan; 278(1):661-71. PubMed ID: 12403768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressor of Cytokine Signaling 3 Is an Inducible Host Factor That Regulates Virus Egress during Ebola Virus Infection.
    Okumura A; Rasmussen AL; Halfmann P; Feldmann F; Yoshimura A; Feldmann H; Kawaoka Y; Harty RN; Katze MG
    J Virol; 2015 Oct; 89(20):10399-406. PubMed ID: 26246577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ASB proteins interact with Cullin5 and Rbx2 to form E3 ubiquitin ligase complexes.
    Kohroki J; Nishiyama T; Nakamura T; Masuho Y
    FEBS Lett; 2005 Dec; 579(30):6796-802. PubMed ID: 16325183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for phosphotyrosine recognition by suppressor of cytokine signaling-3.
    Bergamin E; Wu J; Hubbard SR
    Structure; 2006 Aug; 14(8):1285-92. PubMed ID: 16905102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular architecture of the ankyrin SOCS box family of Cul5-dependent E3 ubiquitin ligases.
    Muniz JR; Guo K; Kershaw NJ; Ayinampudi V; von Delft F; Babon JJ; Bullock AN
    J Mol Biol; 2013 Sep; 425(17):3166-77. PubMed ID: 23806657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Key role of suppressor of cytokine signaling 3 in regulating gp130 cytokine-induced signaling and limiting chondrocyte responses during murine inflammatory arthritis.
    Liu X; Croker BA; Campbell IK; Gauci SJ; Alexander WS; Tonkin BA; Walsh NC; Linossi EM; Nicholson SE; Lawlor KE; Wicks IP
    Arthritis Rheumatol; 2014 Sep; 66(9):2391-402. PubMed ID: 24839265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressor of cytokine signaling 3 regulates CD8 T-cell proliferation by inhibition of interleukins 6 and 27.
    Brender C; Tannahill GM; Jenkins BJ; Fletcher J; Columbus R; Saris CJ; Ernst M; Nicola NA; Hilton DJ; Alexander WS; Starr R
    Blood; 2007 Oct; 110(7):2528-36. PubMed ID: 17609432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.